Literature DB >> 15760580

Premenopausal bone health assessment.

E Michael Lewiecki1.   

Abstract

The World Health Organization criteria for classification of bone mineral density (BMD) cannot be applied to premenopausal women because the relationship between BMD and fracture risk is not the same as in postmenopausal women. Approximately 2.5% of premenopausal women have BMD that is more than 2.0 standard deviations below the mean BMD of an age-, gender-, and ethnicity-matched reference population. Most premenopausal women with low BMD have low peak bone mass and low 5- to 10-year probability of fracture. The management of these patients involves nonpharmacologic lifestyle measures and reassurances that fracture risk is low. A minority of premenopausal women with low BMD have significant elevation of fracture risk, usually a result of contributing diseases, conditions, or medications that may be identified and treated. Premenopausal women with fractures are at increased risk for postmenopausal osteoporosis and fractures later in life.

Entities:  

Mesh:

Year:  2005        PMID: 15760580     DOI: 10.1007/s11926-005-0008-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  58 in total

1.  Characterization of perimenopausal bone loss: a prospective study.

Authors:  R Recker; J Lappe; K Davies; R Heaney
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

2.  Effects of contraceptive use on bone biochemical markers in young women.

Authors:  S M Ott; D Scholes; A Z LaCroix; L E Ichikawa; C K Yoshida; W E Barlow
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

3.  Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Delmas; P Burckhardt; C Cooper; D Torgerson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Oral-contraceptive use and risk of hip fracture: a case-control study.

Authors:  K Michaëlsson; J A Baron; B Y Farahmand; I Persson; S Ljunghall
Journal:  Lancet       Date:  1999-05-01       Impact factor: 79.321

Review 5.  Is this woman perimenopausal?

Authors:  Lori A Bastian; Crystal M Smith; Kavita Nanda
Journal:  JAMA       Date:  2003-02-19       Impact factor: 56.272

6.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

7.  Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

Authors:  T J Powles; T Hickish; J A Kanis; A Tidy; S Ashley
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

8.  Oral contraceptive pill use and fractures in women: a prospective study.

Authors:  C Cooper; P Hannaford; P Croft; C R Kay
Journal:  Bone       Date:  1993       Impact factor: 4.398

9.  Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women.

Authors:  Pilar Peris; Núria Guañabens; Ma Jesús Martínez de Osaba; Ana Monegal; Luisa Alvarez; Francesca Pons; Inmaculada Ros; Dacia Cerdá; José Muñoz-Gómez
Journal:  Semin Arthritis Rheum       Date:  2002-08       Impact factor: 5.532

Review 10.  What are the standards by which bone mass measurement at peripheral skeletal sites should be used in the diagnosis of osteoporosis?

Authors:  Paul D Miller; Christopher F Njeh; Larry G Jankowski; Leon Lenchik
Journal:  J Clin Densitom       Date:  2002       Impact factor: 2.963

View more
  7 in total

Review 1.  Premenopausal bone health: osteoporosis in premenopausal women.

Authors:  Alice Abraham; Adi Cohen; Elizabeth Shane
Journal:  Clin Obstet Gynecol       Date:  2013-12       Impact factor: 2.190

2.  Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.

Authors:  A Cohen; R R Recker; J Lappe; D W Dempster; S Cremers; D J McMahon; E M Stein; J Fleischer; C J Rosen; H Rogers; R B Staron; J Lemaster; E Shane
Journal:  Osteoporos Int       Date:  2011-03-02       Impact factor: 4.507

Review 3.  Treatment of premenopausal women with low bone mineral density.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Curr Osteoporos Rep       Date:  2008-03       Impact factor: 5.096

Review 4.  Common mistakes in the clinical use of bone mineral density testing.

Authors:  E Michael Lewiecki; Nancy E Lane
Journal:  Nat Clin Pract Rheumatol       Date:  2008-10-21

Review 5.  Improving quality of care in osteoporosis: opportunities and challenges.

Authors:  Gim Gee Teng; Amy Warriner; Jeffrey R Curtis; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2008-04       Impact factor: 4.592

6.  Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.

Authors:  Linn Hofsøy Steffensen; Svein Ivar Mellgren; Margitta T Kampman
Journal:  J Neurol       Date:  2009-10-01       Impact factor: 4.849

Review 7.  Endocrine and metabolic manifestations in inflammatory bowel disease.

Authors:  Stelios Tigas; Agathocles Tsatsoulis
Journal:  Ann Gastroenterol       Date:  2012
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.